Bank of America’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2M | Buy |
1,839,315
+264,827
| +17% | +$7.52M | ﹤0.01% | 1475 |
|
|
2025
Q1 | $46.5M | Buy |
1,574,488
+1,395,900
| +782% | +$41.2M | ﹤0.01% | 1464 |
|
|
2024
Q4 | $5.19M | Sell |
178,588
-1,164,431
| -87% | -$33.9M | ﹤0.01% | 3004 |
|
|
2024
Q3 | $61.7M | Buy |
1,343,019
+1,151,748
| +602% | +$52.9M | 0.01% | 1230 |
|
|
2024
Q2 | $7.81M | Buy |
191,271
+9,600
| +5% | +$392K | ﹤0.01% | 2749 |
|
|
2024
Q1 | $4.64M | Sell |
181,671
-78,937
| -30% | -$2.01M | ﹤0.01% | 3113 |
|
|
2023
Q4 | $2.36M | Sell |
260,608
-99,606
| -28% | -$901K | ﹤0.01% | 3499 |
|
|
2023
Q3 | $2.3M | Sell |
360,214
-326,311
| -48% | -$2.08M | ﹤0.01% | 3440 |
|
|
2023
Q2 | $7.61M | Buy |
686,525
+280,031
| +69% | +$3.11M | ﹤0.01% | 2533 |
|
|
2023
Q1 | $6.24M | Buy |
406,494
+162,134
| +66% | +$2.49M | ﹤0.01% | 2831 |
|
|
2022
Q4 | $5.42M | Buy |
244,360
+175,770
| +256% | +$3.9M | ﹤0.01% | 2840 |
|
|
2022
Q3 | $1.12M | Buy |
68,590
+14,090
| +26% | +$230K | ﹤0.01% | 4113 |
|
|
2022
Q2 | $792K | Buy |
54,500
+11,846
| +28% | +$172K | ﹤0.01% | 4419 |
|
|
2022
Q1 | $788K | Sell |
42,654
-46,452
| -52% | -$858K | ﹤0.01% | 4778 |
|
|
2021
Q4 | $2.12M | Buy |
89,106
+66,322
| +291% | +$1.58M | ﹤0.01% | 3851 |
|
|
2021
Q3 | $562K | Sell |
22,784
-9,080
| -28% | -$224K | ﹤0.01% | 4776 |
|
|
2021
Q2 | $788K | Buy |
31,864
+209
| +0.7% | +$5.17K | ﹤0.01% | 4410 |
|
|
2021
Q1 | $691K | Buy |
31,655
+18,051
| +133% | +$394K | ﹤0.01% | 4533 |
|
|
2020
Q4 | $347K | Buy |
+13,604
| New | +$347K | ﹤0.01% | 4553 |
|